Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NewAdisInsight
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NewAdisInsight
-
Are you attending
@PharmaCIConf Asia this December? Visit us at our stand to see how#AdisInsight can help you and receive a FREE competitive intelligence report. To find out more and to pre-register your interest, click here: http://bit.ly/2XIHjEv#PharmaCIpic.twitter.com/dSw24WZx7R
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
Are you attending
@LSAcademy_EasyB Italian#Pharmacovigilance Day next week? Visit us at our stand to see how#AdisPharmacovigilance can help you and receive a FREE safety report. To find out more and to pre-register your interest, click here http://bit.ly/2IxiRPX pic.twitter.com/yxy76Fx6hQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
@NewAdisInsight is attending the @PharmaCIConf in Newark NJ!pic.twitter.com/Bf7J3LpYIf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It's day two
@PharmaCIConf, don’t forget to visit our booth and get your FREE competitive intelligence report.#pharmaciconf#competitiveintelligence#AdisInsightpic.twitter.com/Y2mC7mCSPA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
@MirabileKaren is attending the PharmaCI Conference in Newark NJ. Stop by the@NewAdisInsight booth at the@PharmaCIConf to see how AdisInsight can help you and enter a chance to win an Amazon Echo!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stop by our booth today
@PharmaCIConf USA to see how#AdisInsight can help you and receive a FREE competitive intelligence report.#pharmaciconfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Are you attending
@PharmaCIConf USA this September? Visit us at our stand to see how AdisInsight can help you and receive a FREE competitive intelligence report. To find out more and to pre-register your interest, click here: http://bit.ly/2ktik91#pharmaciconfpic.twitter.com/0PBOgDFdUb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Browse
#diabetes#diabetes mellitus https://goo.gl/MgVtnM from@Springernature. Free content in the form of a virtual issue PLUS two webinars on “Precision Diabetes” and “Future of Insulin”Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
Over 180 articles, book chapters and books by this year’s
#NobelPrize winners have been published by@SpringerNature. Read more in our latest#PressRelease http://bit.ly/2NDe5Aa pic.twitter.com/9iFQWmWGtT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Browse
#alzheimer’s#dementia research https://goo.gl/Vdc23L from@Springernature. Free content in the form of a virtual issue, explore the latest research on diagnosis, treatment and prevention by leveraging a variety of techniques and technologies.pic.twitter.com/S17XIJT2xj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Browse
#cancertreatment research https://goo.gl/VGYKjA from@Springernature incl. webinar about "Innovations & Trends in#oncology" and white paper on “#biomarkers,#mutations and#moleculartargets”Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
Have you viewed the
@SpringerNature 5 Global Grand Challenges Infographic yet? Here's a snippet, but view the entire image here: https://media.springernature.com/full/springer-cms/rest/v1/content/15493506/data/v5 …pic.twitter.com/0hPRNRTTcj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Avatrombopag (
#Doptelet®): First Global Approval – Reducing the bleeding risks of invasive procedures in patients with Chronic Liver Diseasehttps://adisintouch.com/2018/07/31/avatrombopag-first-global-approval-aug-18/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
Interested in seeing how having access to STM content accelerates innovation ? Read the latest
@SpringerNature white paper! From Research to Patent and Back Again: The research needs of R&D professionals https://www.springernature.com/gp/librarians/landing/innovation-patents …pic.twitter.com/fCsCpS2vwP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Erenumab (
#AIMOVIG™) developed by#Amgen and#Novartis: First Global Approval in US followed by Positive CHMP Opinion – Once-monthly prophylactic approach for adults with#Migrainehttps://adisintouch.com/2018/07/31/erenumab-first-global-approval-and-positive-chmp-opinion-jul-18/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AdisInsight proslijedio/la je Tweet
What does it take to write a book that doesn't fit into the traditional academic framework? Tips and advice from a Springer Nature author on the Source blog. http://bit.ly/2Lac0iT pic.twitter.com/ywXITMKkZX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Dupilumab (#Dupixent®):#CADTH Publishes Negative Recommendation for Reimbursement in Canadahttps://adisintouch.com/2018/07/17/dupilumab-negative-recommendation-in-canada-jul-18/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Durvalumab (
#IMFENZI®): Follow up Approval for#NSCLC in Japanhttps://adisintouch.com/2018/07/17/durvalumab-follow-up-nsclc-japan-jul-18/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to present at this year’s
@SpringerNature Better Science through Better Data event in London? Wednesday 14th November 2018. Apply today#scidata18#ResearchData https://researchdata.springernature.com/users/112062-warren-eades/posts/36571-better-science-through-better-data-2018-call-for-lightning-talks-proposals?utm_source=twitter.com&utm_campaign=RSDTscidataLightningtalksLTPTw …pic.twitter.com/P9NB9f0vnl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Call for Papers: Themed Issue – Improving Transparency in Decision Modelshttps://adisintouch.com/2018/07/12/pec-cfp-july18/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.